methyldopa has been researched along with Autoimmune Chronic Hepatitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I | 1 |
Legkova, KS; Topchy, TB; Volchkova, EA | 1 |
Ahrens, W; Bonkovsky, HL; deLemos, AS; Foureau, DM; Jacobs, C; Russo, MW | 1 |
1 review(s) available for methyldopa and Autoimmune Chronic Hepatitis
Article | Year |
---|---|
Drug-induced liver injury with autoimmune features.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Autoantibodies; Autoimmunity; Chemical and Drug Induced Liver Injury; Cytokines; Diagnosis, Differential; Drug Hypersensitivity; Female; Hepatitis, Autoimmune; HLA Antigens; Humans; Hydralazine; Hypergammaglobulinemia; Liver; Liver Function Tests; Male; Methyldopa; Minocycline; Nitrofurantoin; Time Factors; Young Adult | 2014 |
2 other study(ies) available for methyldopa and Autoimmune Chronic Hepatitis
Article | Year |
---|---|
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin | 2022 |
[COVID-19 as a trigger of autoimmune hepatitis. Case report].
Topics: Adult; Antiviral Agents; COVID-19; Diclofenac; Etanercept; Female; Hepatitis, Autoimmune; Humans; Infliximab; Male; Methyldopa; Minocycline | 2022 |